Compare Align Technology, Inc. (ALGN) vs D Wave Quantum Inc (QBTS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs D Wave Quantum Inc — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while D Wave Quantum Inc trades at $19.85 (market cap $7.44B). The key difference: Align Technology, Inc. is the larger of the two by market cap, and Align Technology, Inc. is trading nearer its 52-week high, D Wave Quantum Inc nearer its low. Which is the better fit depends on your goals.
| ALGN | QBTS | |
|---|---|---|
Market Cap | $12.86B | $7.44B |
Sector | Health | Technology |
52-Week High | $207.19 | $44.78 |
52-Week Low | $124.88 | $12.98 |
Enterprise Value | $11.92B | $6.90B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
D-Wave Quantum (QBTS) trades at $20.08, down 5.1% today amid bearish technical signals. The stock shows extreme valuation metrics with P/S of 551.27 and negative profitability, though analyst consensus remains unanimously bullish with a $39.86 price target representing 99% upside. Recent IDC MarketScape recognition and government grants highlight technological progress, but substantial cash burn and negative margins pose fundamental challenges.
While analyst optimism and quantum computing's long-term potential offer speculative appeal, QBTS faces significant execution risks with negative earnings, high cash burn, and competitive threats. The stock's current technical weakness near key support at $20 suggests near-term pressure, making it suitable only for risk-tolerant investors betting on quantum commercialization timelines.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About D Wave Quantum Inc
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →
